Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study

Friedemann Paul, Peter A. Calabresi, Frederik Barkhof, Ari Green, Randy H. Kardon, Jaume Sastre‐Garriga, Sven Schippling, Patrick Vermersch, Shiv Saidha, Bianca S. Gerendas, Ursula Schmidt‐Erfurth, Catherine Agoropoulou, Ying Zhang, Gustavo Seifer, Axel PetzoldAnnals 2021 · DOI

Abstract

OCT has potential to estimate rates of neurodegeneration in the retina and brain. The effect size for OCT, smaller than for magnetic resonance imaging based on Heidelberg Spectralis data acquired in this study, was increased in early disease.
BibTeX
@article{paul2021optical,
  author = {Friedemann Paul and Peter A. Calabresi and Frederik Barkhof and Ari Green and Randy H. Kardon and Jaume Sastre‐Garriga and Sven Schippling and Patrick Vermersch and Shiv Saidha and Bianca S. Gerendas and Ursula Schmidt‐Erfurth and Catherine Agoropoulou and Ying Zhang and Gustavo Seifer and Axel Petzold},
  title = {{Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study}},
  journal = {Annals},
  year = {2021},
  doi = {10.1002/acn3.51473},
}

Loading related content...

Figure